title: Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
abstract: Deletions of the long arm of chromosome 11 (11q) have been noted in primary neuroblastomas, but a comprehensive analysis has not been performed. Therefore, we analysed 331 neuroblastomas (295 sporadic, 15 familial and 21 tumor-derived cell lines) to determine the prevalence of 11q allelic deletions, to map the location of a putative tumor suppressor gene and to perform clinical correlative studies. Assays for loss of heterozygosity (LOH) were performed at 24 microsatellite loci spanning 11q. LOH was observed at multiple 11q loci in 129/295 (44%) sporadic neuroblastomas, 5/15 (33%) familial neuroblastomas, and 5/21 (24%) neuroblastoma cell lines. A single region of 2.1 cM within 11q23.3, flanked by markers D11S1340 and D11S1299, was deleted in all specimens with 11q LOH. Allelic loss at 11q23 was inversely related to MYCN amplification (P<0.001). Within the subset of cases with a single copy of MYCN, 11q LOH was associated with advanced stage disease (P=0.008), unfavorable histopathology (P=0.042), and decreased overall survival probability (P=0.008). However, 11q LOH was not independently prognostic in multivariate analyses. These data support the hypothesis that a tumor suppressor gene mapping within 11q23.3 is commonly inactivated during the malignant evolution of a large subset of neuroblastomas, especially those with unamplified MYCN.
authors.affiliation: Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, PA 19104, USA.
authors.forename: C
authors.initials: C
authors.lastname: Guo
authors.forename: P S
authors.initials: PS
authors.lastname: White
authors.forename: M J
authors.initials: MJ
authors.lastname: Weiss
authors.forename: M D
authors.initials: MD
authors.lastname: Hogarty
authors.forename: P M
authors.initials: PM
authors.lastname: Thompson
authors.forename: D O
authors.initials: DO
authors.lastname: Stram
authors.forename: R
authors.initials: R
authors.lastname: Gerbing
authors.forename: K K
authors.initials: KK
authors.lastname: Matthay
authors.forename: R C
authors.initials: RC
authors.lastname: Seeger
authors.forename: G M
authors.initials: GM
authors.lastname: Brodeur
authors.forename: J M
authors.initials: JM
authors.lastname: Maris
mesh_terms: D000483:Alleles; D002648:Child; D002675:Child, Preschool; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics*; D005260:Female; D005784:Gene Amplification; D018628:Gene Dosage; D016147:Genes, Tumor Suppressor / Q000235:genetics*; D016259:Genes, myc / Q000235:genetics*; D005838:Genotype; D006801:Humans; D007223:Infant; D019656:Loss of Heterozygosity / Q000235:genetics*; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics; D015999:Multivariate Analysis; D009447:Neuroblastoma / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D020161:Physical Chromosome Mapping; D011110:Polymorphism, Genetic / Q000235:genetics; D011379:Prognosis; D017384:Sequence Deletion / Q000235:genetics; D015996:Survival Rate; D014407:Tumor Cells, Cultured